<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cells</journal-id><journal-id journal-id-type="iso-abbrev">Cells</journal-id><journal-id journal-id-type="publisher-id">cells</journal-id><journal-title-group><journal-title>Cells</journal-title></journal-title-group><issn pub-type="epub">2073-4409</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7821929</article-id><article-id pub-id-type="pmid">33374892</article-id><article-id pub-id-type="doi">10.3390/cells10010001</article-id><article-id pub-id-type="publisher-id">cells-10-00001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Metabolite Profiling of <italic>Alangium salviifolium</italic> Bark Using Advanced LC/MS and GC/Q-TOFTechnology</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Siddaiah</surname><given-names>Chandranayaka</given-names></name><xref ref-type="aff" rid="af1-cells-10-00001">1</xref><xref rid="c1-cells-10-00001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8799-5164</contrib-id><name><surname>Kumar BM</surname><given-names>Anil</given-names></name><xref ref-type="aff" rid="af1-cells-10-00001">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9772-7633</contrib-id><name><surname>Deepak</surname><given-names>Saligrama Adavigowda</given-names></name><xref ref-type="aff" rid="af2-cells-10-00001">2</xref></contrib><contrib contrib-type="author"><name><surname>Lateef</surname><given-names>Syed Salman</given-names></name><xref ref-type="aff" rid="af2-cells-10-00001">2</xref><xref ref-type="aff" rid="af3-cells-10-00001">3</xref></contrib><contrib contrib-type="author"><name><surname>Nagpal</surname><given-names>Saurabh</given-names></name><xref ref-type="aff" rid="af2-cells-10-00001">2</xref></contrib><contrib contrib-type="author"><name><surname>Rangappa</surname><given-names>Kanchugarakoppal S.</given-names></name><xref ref-type="aff" rid="af4-cells-10-00001">4</xref></contrib><contrib contrib-type="author"><name><surname>Mohan</surname><given-names>Chakrabhavi D.</given-names></name><xref ref-type="aff" rid="af5-cells-10-00001">5</xref></contrib><contrib contrib-type="author"><name><surname>Rangappa</surname><given-names>Shobith</given-names></name><xref ref-type="aff" rid="af6-cells-10-00001">6</xref></contrib><contrib contrib-type="author"><name><surname>Kumar S</surname><given-names>Madan</given-names></name><xref ref-type="aff" rid="af4-cells-10-00001">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6493-5217</contrib-id><name><surname>Sharma</surname><given-names>Minaxi</given-names></name><xref ref-type="aff" rid="af7-cells-10-00001">7</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Vijai Kumar</given-names></name><xref ref-type="aff" rid="af8-cells-10-00001">8</xref><xref ref-type="aff" rid="af9-cells-10-00001">9</xref><xref rid="c1-cells-10-00001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-cells-10-00001"><label>1</label>Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore 570006, India; <email>anilkumarbm0908@gmail.com</email></aff><aff id="af2-cells-10-00001"><label>2</label>Agilent Technologies India Pvt. Ltd., Bangalore 560048, India; <email>deepak_sa@agilent.com</email> (S.A.D.); <email>syed.lateef1@wipro.com</email> (S.S.L.); <email>saurabh_nagpal@agilent.com</email> (S.N.)</aff><aff id="af3-cells-10-00001"><label>3</label>Wipro Ltd., SEZ, Sarjapura, Bangalore 560099, India</aff><aff id="af4-cells-10-00001"><label>4</label>Institution of Excellence, Vijnana Bhavan, University of Mysore, Manasagangotri, Mysore 570006, Inida; <email>rangappaks@gmail.com</email> (K.S.R.); <email>madan.mx@gmail.com</email> (M.K.S.)</aff><aff id="af5-cells-10-00001"><label>5</label>Department of Studies in Molecular Biology, University of Mysore, Manasagangotri, Mysore 570006, India; <email>cd.mohan@yahoo.com</email></aff><aff id="af6-cells-10-00001"><label>6</label>Adichunchanagiri Institute for Molecular Medicine, AIMS Campus, B. G. Nagar, Mandya 571448, India; <email>shobithrangappa@gmail.com</email></aff><aff id="af7-cells-10-00001"><label>7</label>Department of Food Technology, Akal College of Agriculture, Eternal University, Baru Sahib, Himachal Pradesh 173101, India; <email>minaxi86sharma@gmail.com</email></aff><aff id="af8-cells-10-00001"><label>8</label>Center for Safe and Improved Food, Scotland&#x02019;s Rural College (SRUC), Kings Buildings, West Mains Road, Edinburgh EH9 3JG, UK</aff><aff id="af9-cells-10-00001"><label>9</label>Biorefining and Advanced Materials Research Center, Scotland&#x02019;s Rural College (SRUC), Kings Buildings, West Mains Road, Edinburgh EH9 3JG, UK</aff><author-notes><corresp id="c1-cells-10-00001"><label>*</label>Correspondence: <email>moonnayak@gmail.com</email> (C.S.); <email>vijai.gupta@sruc.ac.uk</email> (V.K.G.); Tel.: +91-988-664-0778 (C.S.); +44-138-724-2920 (V.K.G.)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>10</volume><issue>1</issue><elocation-id>1</elocation-id><history><date date-type="received"><day>10</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>There is an urge for traditional herbal remedies as an alternative to modern medicine in treating several ailments. <italic>Alangium salviifolium</italic> is one such plant, used traditionally to treat several diseases. In several reports, there are findings related to the use of this plant extract that demonstrate its therapeutic value. However, very few attempts have been made to identify the extensive metabolite composition of this plant. Here, we performed metabolite profiling and identification from the bark of <italic>A. salviifolium</italic> by extracting the sample in organic and aqueous solvents. The organic and aqueous extracts were fraction-collected using the Agilent 1260 Analytical Scale Fraction Collection System. Each of the fractions was analyzed on Liquid Chromatogaphy/Quadrupole Time-of-Flight LC/Q-TOF and Gas Chromatography/Quadrupole Time-of-Flight GC/instruments. The Liquid Chromatography/Mass Spectrometry (LC/MS) analyses were performed using Hydrophilic Ineraction Liquid Chromatography (HILIC), as well as reversed-phase chromatography using three separate, orthogonal reverse phase columns. Samples were analyzed using an Agilent Jet Stream (AJS) source in both positive and negative ionization modes. The compounds found were flavonoids, fatty acids, sugars, and terpenes. Eighty-one secondary metabolites were identified as having therapeutic potential. The data produced was against the METLIN database using accurate mass and/or MS/MS library matching. Compounds from <italic>Alangium</italic> that could not be identified by database or library matching were subsequently searched against the ChemSpider) database of over 30 million structures using MSMS data and Agilent MSC software.In order to identify compounds generated by GC/MS, the data were searched against the AgilentFiehn GCMS Metabolomics Library as well as the Wiley/NIST libraries.</p></abstract><kwd-group><kwd><italic>Alangium salviifolium</italic></kwd><kwd>LC/MS</kwd><kwd>GC/Q-TOF</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-cells-10-00001"><title>1. Introduction</title><p>Medicinal plants have the capacity to produce a variety of chemical compounds that are used to perform important biological functions. Majority of health care products available on the market are known to be derived from plants. Recently, the World Health Organization estimated that 80% of the world population relies on herbal medicines for some aspect of their primary health care needs, and, according to them, around 21,000 plant species have the potential to be used medicinally [<xref rid="B1-cells-10-00001" ref-type="bibr">1</xref>].The use of plant-based medications and therapeutics is continuously increasing worldwide; hence, there is high acceptance and demand [<xref rid="B2-cells-10-00001" ref-type="bibr">2</xref>]. <italic>Alangium salviifolium</italic> (L.f) Wang is a medicinal plant reported in Ayurveda and Chinese medicine. This plant is used traditionally to treat several diseases such as cancer, leprosy, diabetes, paralysis, microbial infections, and others. Plant parts such as roots, stems, leaves, flowers, fruits, or the entire plant extract are consumed orally or applied dermally, depending on the type of disease that is treated. Experiments correlating this medicinal plant with specific diseases or activities were reported earlier [<xref rid="B3-cells-10-00001" ref-type="bibr">3</xref>,<xref rid="B4-cells-10-00001" ref-type="bibr">4</xref>,<xref rid="B5-cells-10-00001" ref-type="bibr">5</xref>,<xref rid="B6-cells-10-00001" ref-type="bibr">6</xref>]. This plant extract shows antiepileptic [<xref rid="B7-cells-10-00001" ref-type="bibr">7</xref>], antioxidant/antimicrobial [<xref rid="B8-cells-10-00001" ref-type="bibr">8</xref>], antidiabetic [<xref rid="B9-cells-10-00001" ref-type="bibr">9</xref>], wound healing [<xref rid="B10-cells-10-00001" ref-type="bibr">10</xref>], antiarthritic [<xref rid="B11-cells-10-00001" ref-type="bibr">11</xref>], antibacterial [<xref rid="B12-cells-10-00001" ref-type="bibr">12</xref>], antifertility [<xref rid="B13-cells-10-00001" ref-type="bibr">13</xref>], cardiac [<xref rid="B14-cells-10-00001" ref-type="bibr">14</xref>], anti-inflammatory [<xref rid="B15-cells-10-00001" ref-type="bibr">15</xref>], diuretic [<xref rid="B16-cells-10-00001" ref-type="bibr">16</xref>], and antifungal [<xref rid="B17-cells-10-00001" ref-type="bibr">17</xref>] effects. Comprehensive untargeted metabolomics provides an unbiased analysis of all biochemical intermediates in a sample. This is achieved by using complementary universal analytical techniques such as LC/MS, GC/MS, and NMR. The factors that can affect the evaluation of a metabolome include the method used for sample harvesting/extraction procedures, fractionation, chromatographic separation chemistry, ionization techniques/modes, acquisition parameters, data processing/analysis, and identification [<xref rid="B18-cells-10-00001" ref-type="bibr">18</xref>]. In this study, by using orthogonal LC/MS and GC/MS techniques, we aimed for a comprehensive analysis, including identification of the metabolites present in stem bark for this plant. </p></sec><sec id="sec2-cells-10-00001"><title>2. Materials and Methods</title><sec id="sec2dot1-cells-10-00001"><title>2.1. Reagents and Materials</title><p>LC/MS grade isopropanol, methanol, and acetonitrile were purchased from Fluka (Germany). Milli Q water (Millipore Elix 10 model, Darmstadt, Germany) was used for mobile phase preparation. The additives, namely ammonium fluoride, acetic acid, ammonium formate, formic acid, and ammonium acetate, were procured from Fluka (Germany).</p></sec><sec id="sec2dot2-cells-10-00001"><title>2.2. Workflow</title><p>The workflow followed for this study is outlined in <xref ref-type="fig" rid="cells-10-00001-f001">Figure 1</xref>. </p></sec><sec id="sec2dot3-cells-10-00001"><title>2.3. Collection of Plant Material and Extraction Procedure</title><p>Bark of <italic>A. salviifolium</italic> was collected from the plants near Mysore, India, and immediately transferred to liquid nitrogen and stored in &#x02212;80 &#x000b0;C until further use. Two grams of bark tissue was powdered using a mortar and pestle in the presence of liquid nitrogen. For extraction, 40 mL of degassed solution containing chloroform:methanol:water in the ratio of 1:2.5:1 (<italic>v</italic>/<italic>v</italic>/<italic>v</italic>) was added. The solution was crushed for 5 min, transferred to 1.5 mL eppendorf tubes, and vortexed for 5 min at 4 &#x000b0;C. The tubes were centrifuged at 20,800&#x000d7; <italic>g</italic> for 2 min, and the supernatant was pooled from all the tubes into a glass vial. One milliliter of the supernatant was transferred to the eppendorf tube, and 400 &#x003bc;L of water was added. The tubes were vortexed for 10 s, followed by centrifugation at 20,800&#x000d7; <italic>g</italic> for 2 min. The aqueous (upper) and organic (lower) layers were separated and dried separately in a speed vac (Eppendorf, Hamburg, Germany).</p></sec><sec id="sec2dot4-cells-10-00001"><title>2.4. Fraction Collection</title><p>To the dried aqueous and organic layers, 200 &#x003bc;L of 50:50 and 30:70 of mobile phase A and B of respective fractionation method (see <xref rid="cells-10-00001-t001" ref-type="table">Table 1</xref>) were added. The vials were sonicated to resuspend the compounds. HPLC separation was performed by injecting the resuspended mixtures from 5 vials to an Agilent 1, (Santaclara, CA, USA) 260 Infinity analytical purification system equipped with a 1 mL Manual FL-Injection valve (p/n: 5067-4191).The fractionswerecollected in 45 wells of a 96-well plate and dried in a speed vac. </p></sec><sec id="sec2dot5-cells-10-00001"><title>2.5. Multiple LC/Q-TOF Chromatographic Analysis Conditions</title><p>The dried aqueous fractions were resuspended in 250 &#x003bc;L of 50:50 of methanol:water containing 0.2% acetic acid and sonicated for 10 s, whereas the organic fractionsweresuspended in 30:70 of mobile phase A and B (<xref rid="cells-10-00001-t002" ref-type="table">Table 2</xref>&#x02014;organic), followed by centrifugation at 3000 rpm for 10 min. Five microliters of the resuspended fractionswas injected into an Agilent 1260 Infinity LC System, interfaced to an Agilent 6540 accurate mass Q-TOF LC/MS system (Santa clara, CA, USA). The reference solution was prepared using API-TOF Reference Mass Solution Kit (p/n: G1969-85001 (Santa clara, California, USA).Ten microliters of HP921 and 5 &#x003bc;L of purine were dissolved in one liter of methanol:acetonitrile:water (750:200:50) containing 0.1% acetic acid and were sprayed using an isocratic pump at a flow rate of 0.4 mL/min. The chromatographic parameters are shown in <xref rid="cells-10-00001-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec2dot6-cells-10-00001"><title>2.6. GC/Q-TOF Conditions</title><p>The derivatization and experimental parameters for both aqueous and organic fractions were performed as described elsewhere [<xref rid="B19-cells-10-00001" ref-type="bibr">19</xref>]. Agilent 7200 GC/Q-TOF (Santa clara, CA, USA) was used for acquisition with absolute retention times, which was locked to the internal standard d27 myristic acid from the Agilent Fiehn GC/MS Metabolomics Standards Kit (Part Number 400505; (Santa clara, CA, USA).with a retention time locking (RTL) software system. The GC/Q-TOF conditions used are provided in <xref rid="cells-10-00001-t003" ref-type="table">Table 3</xref>. </p></sec><sec id="sec2dot7-cells-10-00001"><title>2.7. Data Analysis</title><p>Agilent MassHunter Qualitative Analysis (version B.06.00 SP1) software (Santa clara, CA, USA) was used for processing MS and AutoMSMS data acquired using LC/GC/Q-TOF. The accurate mass MS data were processed using the tool &#x0201c;Find by Molecular Feature&#x0201d; to export the compounds to Agilent Mass Profiler Professional (MPP) software (Santa clara, CA, USA). In order to remove the molecular features arising from the background, the data obtained from each fraction were background-subtracted using the blank data again in MPP. The ID browser software was used to identify putative compounds by searching against the METLIN database (MassHunter PCDL Manager version B.04.00), which has 64,092 compounds. The GC/Q-TOF data were processed using MassHunter Unknown Analysis software (version B.06.00(Santa clara, CA, USA)). This software uses mass spectral deconvolution, which automatically finds peaks and deconvolutes spectra from co-eluting compounds using model ion traces. The spectral information was matched with the Agilent Fiehn library with retention time index with respect to FAME mix (Agilent Fiehn GC/MS Metabolomics Standards Kit, Part Number 400505). The data were also searched against NIST 11 and Wiley 9 mass spectral libraries. The compounds with library match scores &#x0003e;70% were considered and were searched in the literature for their therapeutic importance.</p><p>The LC-MS/MS data were processed by using the tool &#x0201c;Find by AutoMSMS&#x0201d;, and the spectral pattern generated was searched against the METLIN metabolite library, comprising accurate mass MS/MS information for 19,714 compounds. A few selected compounds found in <italic>Alangium</italic> species that were detected in METLIN database but lacked entry in METLIN library were processed using Molecular Structure Correlator software (MSC) (Santa clara, CA, USA). The MSC software (version B.05.00 build 19) performs systematic in silico bond breaking for the proposed structure and matches with the observed fragment ions, followed by assignment of an overall score. Here, the interface provided visualizations of the formula and the overall score, which was combined from the MS and MSMS score, along with the molecular formulas for the fragment ions with ppm <italic>m/z</italic> error.</p></sec></sec><sec sec-type="results" id="sec3-cells-10-00001"><title>3. Results and Discussion</title><p>In this study, we performed a comprehensive analysis of <italic>A. salviifolium</italic> bark metabolites using multi-separation protocols/ionization modes and multi-platform approaches. Initially, we performed fraction collection of the aqueous and organic extracts by injecting 1 mL of the extract for preliminary separation and enrichment of the metabolites. The Accurate Mass MS results when matched with METLIN database tentatively found 954 compounds with database match score &#x0003e;90%. Literature search revealed 81 of 954 compounds have therapeutic properties. The majority of these therapeutic compounds were secondary metabolites that are reported to have anti-cancer and anti-inflammatory activities (<xref ref-type="fig" rid="cells-10-00001-f002">Figure 2</xref>). These compounds belonged to various plant secondary metabolite classes such as terpenoids, flavonoids, saponins, alkaloids, glycosides, etc. AutoMSMS analysis of all fractions resulted in identification of 449 compounds.</p><p>Five compounds reported to be present commonly in <italic>Alangium</italic> species could not be identified in this study by LC-MS/MS spectral matching, since the spectra for these compounds were not available in the METLIN MSMS library. The spectral information was used to identify the compounds by using Agilent MassHunter MSC software (<xref ref-type="fig" rid="cells-10-00001-f003">Figure 3</xref>). The overall MSC score for all the compounds was &#x0003e;97%, except for cephaeline which was 80%. Using the accurate mass precursor and fragment ion information for cephaeline, and the METLIN accurate mass database, we were able to identify the putative structures based on the MSMS spectra obtained for cephaeline (<xref ref-type="fig" rid="cells-10-00001-f004">Figure 4</xref>). Thus, using MSC for tentative ID confirmation can be a useful tool in shortlisting the number of compounds for subsequent confirmation using actual standards. <xref rid="cells-10-00001-t004" ref-type="table">Table 4</xref> shows the <italic>Alangium</italic> compounds identified by MSC software.</p><p>The separation chemistries for LC-MS/MS were performed using HILIC and three orthogonal reverse phase columns (ZORBAX Eclipse Plus C18, SB-AQ, and Phenyl Hexyl) for the separation of hydrophilic and hydrophobic compounds, respectively. The maximum number of compounds were identified in C18 (197) followed by SB-AQ (187), HILIC (175), and Phenyl Hexyl (139) columns (<xref ref-type="fig" rid="cells-10-00001-f005">Figure 5</xref>). Significant compound overlaps were found between HILIC/SB-AQ and C18/Phenyl Hexyl columns: 53 and 59 compounds, respectively. Only 10 compounds were common to all 4 column types. The three different reverse phase columns, namely C18, SB-AQ, and Phenyl Hexyl, separated 79, 73, and 28 unique compounds, respectively, and HILIC revealed 80 unique compounds. Similar observations on enhanced metabolite coverage have been made by using HILIC and a reverse phase C18 column [<xref rid="B20-cells-10-00001" ref-type="bibr">20</xref>]. Our results using three different RP columns (for non-polar and intermediate polar), along with a HILIC (for polar compounds), clearly reveal the requirement for different separation chemistries for uncompromised metabolomics study.</p><p>The compounds obtained from MS/MS analyses in positive and negative ionization modes are summarized in <xref ref-type="fig" rid="cells-10-00001-f006">Figure 6</xref>. Clear differentiation of compounds for both ionization modes was observed for all the column chemistries used in the study. Many sugars and acidic amino acids were detected by negative mode ionization compared to positive mode ionization. Less than nine compounds were common for positive and negative ionization modes among all the column types. This clearly reveals that use of single ionization mode could significantly reduce the coverage of metabolites.</p><p>The screen shot of unknown analysis software is shown in <xref ref-type="fig" rid="cells-10-00001-f007">Figure 7</xref>. This software provides the features for visualization of the chromatograms, spectrum comparison, query vs. database spectrum alignment, molecular structure, and the components. The components comprise details for each compound.</p><p>The compounds found by GC/Q-TOF were mostly flavonoids, fatty acids, sugars, terpenes, etc. As an example, D-lyxose identified from GC/Q-TOF analysis of aqueous extract using MassHunter Unknown Analysis software is shown in <xref ref-type="fig" rid="cells-10-00001-f008">Figure 8</xref>. The top trace is the acquired GC/Q-TOF spectra, while the bottom trace is the Fiehn library spectra. The matching score was89.6. In addition, the retention time (RT) in the library (14.74 min) matched the RT of the acquired spectra (14.75 min).</p><p>The LC/Q-TOF and GC/Q-TOF analysis resulted in identification of 449 and 62 compounds, respectively. The enhanced number of compounds observed for LC/Q-TOF was primarily due to the use of orthogonal separations. It is well established that LC/MS and GC/MS are complementary techniques for comprehensive metabolomics in order to identify non-volatile and volatile compounds (<xref ref-type="fig" rid="cells-10-00001-f009">Figure 9</xref>).</p></sec><sec sec-type="conclusions" id="sec4-cells-10-00001"><title>4. Conclusions</title><p>This study demonstrates the utility of applying a comprehensive metabolite separation and detection strategy to aid in identification of metabolites in <italic>A. salviifolium</italic> bark. A multi-platform approach was used to detect compounds with different degrees of polarity. In addition, fractionation was used for enrichment, as well as four different column chemistries, along with two ionization modes for increasing the total number of metabolites identified. The compounds not found in the METLIN library were identified by using MSC software. Eighty-one secondary metabolites, such as ankorine, deooxytubulosine, ipecac, lacinilene C7-methyl ether, tubulosine, etc., which were identified in this study, are reported to have therapeutic value.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge the recognition of University of Mysore as an Institution of Excellence and financial support from the Ministry of Human Resource Development, Government of India through the University Grants Commission, New Delhi, India. The authors would like to extend their sincere appreciation to the DST-PURSE program funded by the Department of Science and Technology for providing infrastructure and other research facilities.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceived and designed the experiments: C.S., A.K.B., K.S.R., C.D.M., S.R., M.K., M.S., V.K.G., Performed the experiments: S.A.D., S.S.L., S.N. Analyzed the data: S.S.L., S.A.D., C.S. Wrote the paper C.S., S.A.D., C.D.M., A.K.B. Review: S.N., S.R., M.S., M.K.S., K.S.R., V.K.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-cells-10-00001"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>D.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Sussman</surname><given-names>M.R.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name></person-group><article-title>The effect of developmental and environmental factors on secondary metabolites in medicinal plants</article-title><source>Plant Physiol. Biochem.</source><year>2020</year><volume>148</volume><fpage>80</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.plaphy.2020.01.006</pub-id><?supplied-pmid 31951944?><pub-id pub-id-type="pmid">31951944</pub-id></element-citation></ref><ref id="B2-cells-10-00001"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>M.S.A.</given-names></name><name><surname>Saleem</surname><given-names>H.</given-names></name><name><surname>Ahemad</surname><given-names>N.</given-names></name></person-group><article-title>Plant Extracts and their Secondary Metabolites as Modulators of Kinases</article-title><source>Curr. Top. Med. Chem.</source><year>2020</year><volume>20</volume><fpage>1093</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.2174/1568026620666200224100219</pub-id><?supplied-pmid 32091334?><pub-id pub-id-type="pmid">32091334</pub-id></element-citation></ref><ref id="B3-cells-10-00001"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkateshwarlu</surname><given-names>R.</given-names></name><name><surname>Raju</surname><given-names>A.B.</given-names></name><name><surname>Yerragunta</surname><given-names>V.G.</given-names></name></person-group><article-title>Phytochemistry and pharmacology of Alangium salvifolium: A review</article-title><source>J. Pharm. Res.</source><year>2011</year><volume>4</volume><fpage>1423</fpage><lpage>1425</lpage></element-citation></ref><ref id="B4-cells-10-00001"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjum</surname><given-names>A.</given-names></name><name><surname>Haque</surname><given-names>M.E.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Sarker</surname><given-names>S.D.</given-names></name></person-group><article-title>Antibacterial compounds from the flowers of Alangium salviifolium</article-title><source>Fitoterapia</source><year>2002</year><volume>73</volume><fpage>526</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(02)00178-8</pub-id><pub-id pub-id-type="pmid">12385881</pub-id></element-citation></ref><ref id="B5-cells-10-00001"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Commisso</surname><given-names>M.</given-names></name><name><surname>Strazzer</surname><given-names>P.</given-names></name><name><surname>Toffali</surname><given-names>K.</given-names></name><name><surname>Stocchero</surname><given-names>M.</given-names></name><name><surname>Guzzo</surname><given-names>F.</given-names></name></person-group><article-title>Untargeted metabolomics: An emerging approach to determine the composition of herbal products</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2013</year><volume>4</volume><fpage>e201301007</fpage><pub-id pub-id-type="doi">10.5936/csbj.201301007</pub-id><pub-id pub-id-type="pmid">24688688</pub-id></element-citation></ref><ref id="B6-cells-10-00001"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murugan</surname><given-names>V.</given-names></name><name><surname>Shareef</surname><given-names>H.</given-names></name><name><surname>Rama Sarma</surname><given-names>G.V.S.</given-names></name><name><surname>Ramanathan</surname><given-names>M.</given-names></name><name><surname>Suresh</surname><given-names>B.</given-names></name></person-group><article-title>Anti-fertility activity of the stem bark of Alangium salviifolium (Linn. f.) Wang in wistar female rats</article-title><source>Indian J. Pharmacol.</source><year>2000</year><volume>32</volume><fpage>388</fpage><lpage>389</lpage></element-citation></ref><ref id="B7-cells-10-00001"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambawade</surname><given-names>S.D.</given-names></name><name><surname>Kasture</surname><given-names>V.S.</given-names></name><name><surname>Kasture</surname><given-names>S.B.</given-names></name></person-group><article-title>Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra</article-title><source>Indian J. Pharmacol.</source><year>2002</year><volume>34</volume><fpage>251</fpage><lpage>255</lpage></element-citation></ref><ref id="B8-cells-10-00001"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vineet</surname><given-names>C.J.</given-names></name><name><surname>Patel</surname><given-names>N.M.</given-names></name><name><surname>Dhiren</surname><given-names>P.</given-names></name></person-group><article-title>Antioxidant and Antimicrobial Activities of Alangium salvifolium (L.F) Wang Root</article-title><source>Glob. J. Pharmacol.</source><year>2010</year><volume>4</volume><fpage>13</fpage><lpage>18</lpage></element-citation></ref><ref id="B9-cells-10-00001"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalarani</surname><given-names>D.</given-names></name><name><surname>Dinakar</surname><given-names>A.</given-names></name><name><surname>Senthilkumar</surname><given-names>N.</given-names></name></person-group><article-title>Hypoglycemic and Antidiabetic activity of Alangium salvifolium wang in Alloxan Induced Diabetic Rats</article-title><source>Asian J. Pharm. Clin. Res.</source><year>2011</year><volume>4</volume><fpage>131</fpage><lpage>133</lpage></element-citation></ref><ref id="B10-cells-10-00001"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasekaran</surname><given-names>A.</given-names></name><name><surname>Rajamanickam</surname><given-names>V.</given-names></name><name><surname>Sivagnanam</surname><given-names>G.</given-names></name></person-group><article-title>Anthelmintic activity of the root extract of Alangium salvifolium</article-title><source>J. Trop. Med. Plants</source><year>2008</year><volume>8</volume><fpage>39</fpage><lpage>42</lpage></element-citation></ref><ref id="B11-cells-10-00001"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jubie</surname><given-names>S.</given-names></name><name><surname>Jawahar</surname><given-names>N.</given-names></name></person-group><article-title>Anti-Arthritic Activity of Bark Extracts of Aalangium salviifolium wang</article-title><source>Rasayan J. Chem.</source><year>2008</year><volume>1</volume><fpage>433</fpage><lpage>436</lpage></element-citation></ref><ref id="B12-cells-10-00001"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahan</surname><given-names>R.</given-names></name><name><surname>Mosaddik</surname><given-names>M.A.</given-names></name><name><surname>Barman</surname><given-names>R.K.</given-names></name><name><surname>Wahed</surname><given-names>M.I.I.</given-names></name><name><surname>Haque</surname><given-names>M.E.</given-names></name></person-group><article-title>Antibacterial and antidiarrhoeal activity of Alangium salviifolium Wang flowers</article-title><source>Mol. Clin. Pharmacol.</source><year>2012</year><volume>2</volume><fpage>34</fpage><lpage>43</lpage></element-citation></ref><ref id="B13-cells-10-00001"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panara</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>P.K.</given-names></name><name><surname>Rawat</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Maruf</surname><given-names>M.</given-names></name><name><surname>Patel</surname><given-names>K.</given-names></name><name><surname>Ravikumar</surname><given-names>R.K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>Importance of Alangium salviifolium and Its Pharmacological Update</article-title><source>J. Medicinal Plants</source><year>2016</year><volume>12</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.9734/EJMP/2016/23899</pub-id></element-citation></ref><ref id="B14-cells-10-00001"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muralikrishna</surname><given-names>K.S.</given-names></name><name><surname>Latha</surname><given-names>K.P.</given-names></name><name><surname>Shreedhara</surname><given-names>C.S.</given-names></name><name><surname>Vaidya</surname><given-names>V.P.</given-names></name><name><surname>Krupanidhi</surname><given-names>A.M.</given-names></name></person-group><article-title>Effect of Bauhinia purpurea Linn. on Alloxan-induced diabetic rats and isolated frog&#x02019;s heart</article-title><source>Int. J. Green Pharm.</source><year>2008</year><volume>2</volume><fpage>83</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.4103/0973-8258.41176</pub-id></element-citation></ref><ref id="B15-cells-10-00001"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>M.H.</given-names></name><name><surname>Nguyen</surname><given-names>H.D.</given-names></name></person-group><article-title>Phenolic glycosides from Alangium salviifolium leaves with inhibitory activity on LPS-induced NO, PGE2, and TNF-a production</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2009</year><volume>19</volume><fpage>4389</fpage><lpage>4393</lpage><?supplied-pmid 19500975?><pub-id pub-id-type="pmid">19500975</pub-id></element-citation></ref><ref id="B16-cells-10-00001"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajamanickam</surname><given-names>V.</given-names></name><name><surname>Rajasekaran</surname><given-names>A.</given-names></name></person-group><article-title>Diuretic activity of Alangium salvifolium sub.sp.hexapetalum</article-title><source>Int. J. Alt. Med.</source><year>2009</year><volume>8</volume><fpage>1</fpage></element-citation></ref><ref id="B17-cells-10-00001"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuthi-udomlert</surname><given-names>M.</given-names></name><name><surname>Prathanturarug</surname><given-names>S.</given-names></name><name><surname>Wongkrajang</surname><given-names>Y.</given-names></name></person-group><article-title>Antifungal activity and local toxicity study of Alangium salviifolium subsp hexapetalum</article-title><source>Southeast Asian J. Trop. Med. Public Health</source><year>2002</year><volume>33</volume><fpage>152</fpage><lpage>154</lpage><?supplied-pmid 12971498?><pub-id pub-id-type="pmid">12971498</pub-id></element-citation></ref><ref id="B18-cells-10-00001"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>X.X.</given-names></name></person-group><article-title>Functional metabolomics: From biomarker discovery to metabolome reprogramming</article-title><source>Protein Cell</source><year>2015</year><volume>6</volume><fpage>628</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1007/s13238-015-0185-x</pub-id><?supplied-pmid 26135925?><pub-id pub-id-type="pmid">26135925</pub-id></element-citation></ref><ref id="B19-cells-10-00001"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palazoglu</surname><given-names>M.</given-names></name><name><surname>Fiehn</surname><given-names>O.</given-names></name></person-group><article-title>Metabolite Identification in Blood Plasma Using GC/MS and the Agilent Fiehn GC/MS Metabolomics RTL Library</article-title><source>Agil. Appl. Note</source><year>2009</year><volume>5</volume><fpage>97</fpage><lpage>109</lpage></element-citation></ref><ref id="B20-cells-10-00001"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aurand</surname><given-names>C.R.</given-names></name><name><surname>Bell</surname><given-names>D.S.</given-names></name><name><surname>Lamb</surname><given-names>T.</given-names></name><name><surname>Bell-Pedersen</surname><given-names>D.</given-names></name></person-group><article-title>Metabolomic Profiling of Neurospora crassa Fungi Using HILIC and Reversed Phase LC-MS</article-title><source>Reporter</source><year>2014</year><volume>56</volume><fpage>13</fpage><lpage>14</lpage></element-citation></ref></ref-list></back><floats-group><fig id="cells-10-00001-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Summary of the workflow for biphasic solvent extraction followed by analysis using LC/MS and GC/MS platforms.</p></caption><graphic xlink:href="cells-10-00001-g001"/></fig><fig id="cells-10-00001-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>METLIN database matched compounds from <italic>Alangium salviifolium</italic> and grouped by therapeutic use (<bold>A</bold>) and compound class (<bold>B</bold>) based on literature reports.</p></caption><graphic xlink:href="cells-10-00001-g002"/></fig><fig id="cells-10-00001-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Results from Agilent MSC software tool for identifying the compounds that did not have a spectral match in the METLIN MSMS library.</p></caption><graphic xlink:href="cells-10-00001-g003"/></fig><fig id="cells-10-00001-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Proposed metabolite fragment structures for cephaeline based on MSC analysis.</p></caption><graphic xlink:href="cells-10-00001-g004"/></fig><fig id="cells-10-00001-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>METLIN library matched compound distribution based on column chemistry. Figure drawn using MPP Software.</p></caption><graphic xlink:href="cells-10-00001-g005"/></fig><fig id="cells-10-00001-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>METLIN library matched compounds distribution based on ionization modes.</p></caption><graphic xlink:href="cells-10-00001-g006"/></fig><fig id="cells-10-00001-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Fiehn/Wiley/NIST library matched analysis using Agilent MassHunter Unknown Analysis software.</p></caption><graphic xlink:href="cells-10-00001-g007"/></fig><fig id="cells-10-00001-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>GC/Q-TOF spectral search results.</p></caption><graphic xlink:href="cells-10-00001-g008"/></fig><fig id="cells-10-00001-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Compounds identified usingLC/Q-TOF and GC/Q-TOF analyses.</p></caption><graphic xlink:href="cells-10-00001-g009"/></fig><table-wrap id="cells-10-00001-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">cells-10-00001-t001_Table 1</object-id><label>Table 1</label><caption><p>Chromatographic parameters for fractionation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameters</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Aqueous Extract</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Organic Extract</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Mobile phase A: Water + 10 mM ammonium acetate <break/>Mobile phase B: 100% Acetonitrile</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Mobile phase A: 95:5 Water:methanol with 0.1% formic acid and 5 mM ammonium formate<break/>Mobile phase B: 65:30:5 Isopropanol:methanol:water with 0.1% formic acid and 5 mM ammonium formate</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flow rate</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">1.2 mL/min</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">1.2 mL/min</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection volume</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">1 mL</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">0.3 mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thermostat autosampler</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4 &#x000b0;C</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4 &#x000b0;C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Temperature TCC</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">25 &#x000b0;C</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">25 &#x000b0;C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DAD</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">210 and 254 nm</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">210 and 254 nm</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peak width</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">&#x0003e;0.05 min</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">&#x0003e;0.05 min</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fraction collection mode</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Time based</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Time based</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total time </td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">13 min</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">13 min</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Column</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">ZORBAX SB-C18(9.4 &#x000d7; 50 mm, 5 &#x000b5;m, p/n: 846975-202)</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">ZORBAX SB-C18(9.4 &#x000d7; 50 mm, 5 &#x000b5;m, p/n: 846975-202)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time slices</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">0.292 min/well</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">0.292 min/well</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gradient </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)<break/>0.0<break/>1.0<break/>8.0<break/>8.1<break/>10.0<break/>10.1<break/>12.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% Solvent B<break/>5<break/>5<break/>35<break/>95<break/>95<break/>5<break/>5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)<break/>0.0<break/>1.0<break/>8.0<break/>11.0<break/>11.1<break/>12.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% Solvent B<break/>60<break/>60<break/>100<break/>100<break/>60<break/>60</td></tr></tbody></table></table-wrap><table-wrap id="cells-10-00001-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">cells-10-00001-t002_Table 2</object-id><label>Table 2</label><caption><p>Chromatographic parameters used in the LC/MS and LC-MS/MS analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Parameter </th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Aqueous Fractions Analysed Using ZORBAX SB-AQ Column </th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Aqueous Fractions Analysed Using ZORBAC HILIC Column</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ionization mode </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive MS and positive AutoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative MS and Negative AutoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive MS and positive AutoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative MS and Negative AutoMSMS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase A: Water with 0.2% acetic acid<break/>Mobile phase B: Methanol with 0.2% acetic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase A: Water with 1 mM ammonium fluoride acetic acid<break/>Mobile phase B: 100% Acetonitrile</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase A: 90:10 of Acetonitrile: 50 mM ammonium acetate<break/>Mobile phase B: 50:40:10 of acetonitrile:water:50 mM ammonium acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase A: 90:10 of Acetonitrile:50 mM ammonium acetate<break/>Mobile phase B: 50:40:10 of acetonitrile:water:50 mM ammonium acetate</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">LC gradient </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% mobile phase B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% mobile phase B</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.00 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parameter</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Organic fractions analysed using ZORBAX EP-C18</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Organic fractions analysed using ZORBAX EP Phenyl Hexyl</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ionization mode </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive MS and positive utoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative MS and Negative AutoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive MS and positive AutoMSMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative MS and Negative AutoMSMS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mobile phase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95:5 of water: Methanol with 0.1% formic acid and 5 mM ammonium formate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65:30:5 of Isopropanol:methanol: water with 0.1% formic acid and 5 mM ammonium formate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95:5 of water: Methanol with 0.1% formic acid and 5 mM ammonium formate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65:30:5 of Isopropanol:methanol: water with 0.1% formic acid and 5 mM ammonium formate</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">LC gradient </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% of mobile phase B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Time (min)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% of mobile phase B</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.00 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.00</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.0</td></tr></tbody></table></table-wrap><table-wrap id="cells-10-00001-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">cells-10-00001-t003_Table 3</object-id><label>Table 3</label><caption><p>Conditions used for GC/Q-TOF.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">
<bold>GC Conditions</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Column</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DB-5 ms: 30 m &#x000d7; 0.25 mmID &#x000d7; 0.25 &#x003bc;m, Guard Length: 10 m<break/>(Part No. 122-5532G)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection volume</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 &#x000b5;L</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Split mode and ratio</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Split 10:1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Split/Splitless inlet temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250 &#x000b0;C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oven temperature program</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 &#x000b0;C for 1 min<break/>10 &#x000b0;C/min to 325 &#x000b0;C, 10 min hold</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carrier gas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Helium at 1.2798 mL/min constant flow</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transfer line temperature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">290 &#x000b0;C</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>QTOF Conditions</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ionization mode</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EI</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Source temperature </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">230 &#x000b0;C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quadrupole temperature </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">150 &#x000b0;C</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>m/z</italic> scan </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 to 600 <italic>m/z</italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spectral acquisition rate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 spectra/s, 2679 transients/spectrum, collecting both in centroid and profile modes</td></tr></tbody></table></table-wrap><table-wrap id="cells-10-00001-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">cells-10-00001-t004_Table 4</object-id><label>Table 4</label><caption><p>Compounds found in <italic>Alangium</italic> species identified by Agilent MSC Software.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Metabolite</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CAS/KEGG</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formula </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mass Difference (ppm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Overall<break/>Score</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Confirmed by MSC</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ankorine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13849-54-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C19 H29 N O4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;2.56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YES</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deoxytubulosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C11817</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C29 H37 N3 O2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YES</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ipecac (Cephaeline)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">483-17-0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C28 H38 N2 O4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;0.28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YES</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lacinilene C 7-methyl ether</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56362-72-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C16 H20 O3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;1.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YES</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2632-29-3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C29 H37 N3 O3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YES</td></tr></tbody></table></table-wrap></floats-group></article>